The gene copy number variation data is supported by analysis of the RNA sequencing data, which also indicates a significant downregulation of DYRK1A in most, but not all cancer types (Boni et al., 2020; Laham et al., 2021). The gene discussed is DYRK1A; the disease is cancer.